Completed

The Effect of Various Modes of Vibroacoustic Therapy on the Course of Coronavirus Infection Complicated by Acute Respiratory Failure.

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being tested

Vibrolung

Device
Who is being recruted

COVID-19+9

+ Coronaviridae Infections

+ Infections

Over 18 Years
+10 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Treatment Study

Interventional
Study Start: November 2021
See protocol details

Summary

Principal SponsorAstana Medical University
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: November 9, 2021

Actual date on which the first participant was enrolled.

Assessment of the dynamics of changes in physical, instrumental and laboratory parameters in patients with identified coronavirus infection complicated by acute respiratory failure included in the study in accordance with the inclusion criteria, and comparison of the results with the control group, study of the effect of modes when using vibroacoustic lung therapy.

Official TitleThe Effect of Various Modes of Vibroacoustic Therapy on the Course of Coronavirus Infection Complicated by Acute Respiratory Failure.
NCT05143372
Principal SponsorAstana Medical University
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

60 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Treatment Study

These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

COVID-19Coronaviridae InfectionsInfectionsLung DiseasesPneumoniaPneumonia, ViralRespiratory Tract DiseasesRespiratory Tract InfectionsRNA Virus InfectionsVirus DiseasesCoronavirus InfectionsNidovirales Infections

Criteria

3 inclusion criteria required to participate
adults
P/F less 300 torr
COVID-19 Virus Infection
7 exclusion criteria prevent from participating
children
acute stroke
acute coronary syndrome
DVT
Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

2 intervention groups are designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Active Comparator
Measurment 4 times per day, ABA (acid-bases analyses)

Group II

Active Comparator
Measurment 4 times per day, ABA (acid-bases analyses)

Study Objectives

Primary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 3 locations

Suspended

NATIONAL CENTER Scientific Center of Traumatology and Orthopedics named after Academician Batpenov N.D.

Astana, KazakhstanOpen NATIONAL CENTER Scientific Center of Traumatology and Orthopedics named after Academician Batpenov N.D. in Google Maps
Suspended

Multidisciplinary city hospital No. 3 of Nursultan

Astana, Kazakhstan
Suspended

Multidisciplinary Infectious Diseases Hospital of Nursultan

Astana, Kazakhstan
Completed3 Study Centers